Table 1

Associations and comparisons between Rsf-1 expression and clinicopathological factors in 172 rectal cancer patients receiving neoadjuvant chemoradiation therapy

Parameter	No.	Rsf-1 expression		p Value
Parameter	No.	Low exp.	High exp.	p Value
Gender
Male	108	54	54	0.428
Female	64	36	28
Age
<70	106	52	54	0.277
≧70	66	38	28
Pre-treatment tumour status (Pre-T)
T1–T2	81	50	31	0.020^*
T3–T4	91	40	51
Pre-treatment nodal status (Pre-N)
N0	125	64	61	0.630
N (+)	47	26	21
Post-treatment tumour status (Post-T)
T1–T2	86	59	27	<0.001^*
T3–T4	86	31	55
Post-treatment nodal status (Post-N)
N0	123	67	56	0.372
N1–N2	49	23	26
Vascular invasion
Absent	157	84	73	0.317
Present	15	6	9
Perineurial invasion
Absent	167	88	79	0.575
Present	5	2	3
Tumour regression grade
Grade 0–1	37	14	23	0.028^*
Grade 2–3	118	63	55
Grade 4	17	13	4

↵* Statistically significant.